Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).
J Cyst Fibros
; 10 Suppl 2: S67-74, 2011 Jun.
Article
en En
| MEDLINE
| ID: mdl-21658644
ABSTRACT
We describe the rationale for disease specific research networks in general as well as the aims and function of the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) specifically. The ECFS-CTN was founded in 2009 with the aim of improving the quality and quantity of clinical research in the area of cystic fibrosis (CF) in Europe. A network of 18 clinical trial sites in 8 European countries was established according to uniform state-of-the-art quality criteria. To support the ECFS-CTN in the acquisition, planning and conduct of clinical trials, the network is equipped with a coordinating centre, steering and executive committees, and committees for protocol review, standardization, training and networking as well as a data safety monitoring board. A strong partnership with European CF patient parent organizations aims to increase awareness of the need for efficient clinical research and the participation of patients in clinical trials.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Sociedades Médicas
/
Ensayos Clínicos como Asunto
/
Fibrosis Quística
Tipo de estudio:
Guideline
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Cyst Fibros
Año:
2011
Tipo del documento:
Article